Mateja Vrecer

Director/Board Member at KRKA, D. D.

57 year

Health Technology

Profile

Mateja Vrecer has held positions at KRKA dd and KRKA Farmaceutici Milano SRL.
Currently, Dr. Vrecer is an Independent Member-Supervisory Board at KRKA dd and a Member-Supervisory Board at KRKA Farmaceutici Milano SRL.

Mateja Vrecer active positions

Companies	Position	Start
KRKA, D. D.	Director/Board Member	2004-12-31
KRKA Farmaceutici Milano SRL KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The private company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004.	Director/Board Member	2004-12-31

All active positions of Mateja Vrecer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mateja Vrecer's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
KRKA, D. D.	Health Technology

Private companies	1
KRKA Farmaceutici Milano SRL KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The private company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004.	Health Technology